OA
Oak Associates Portfolio holdings
AUM
$1.53B
1-Year Return
20.93%
This Quarter Return
+7.19%
1 Year Return
+20.93%
3 Year Return
+113.44%
5 Year Return
+164.39%
10 Year Return
+515.4%
AUM
$1.5B
AUM Growth
+$7.34M
(+0.49%)
Cap. Flow
-$68.7M
Cap. Flow
% of AUM
-4.59%
Top 10 Holdings %
Top 10 Hldgs %
46.64%
Holding
137
New
2
Increased
21
Reduced
46
Closed
6
Top Buys
| 1 |
DraftKings
DKNG
|
$9.39M |
| 2 |
Intuitive Surgical
ISRG
|
$6.02M |
| 3 |
PayPal
PYPL
|
$5.94M |
| 4 |
Digital Realty Trust
DLR
|
$3.38M |
| 5 |
Akamai
AKAM
|
$1.57M |
Top Sells
| 1 |
Seagate
STX
|
$10M |
| 2 |
IBM
IBM
|
$7.39M |
| 3 |
Amazon
AMZN
|
$5.61M |
| 4 |
JNPR
Juniper Networks
JNPR
|
$5.37M |
| 5 |
Microsoft
MSFT
|
$5.26M |
Sector Composition
| 1 | Technology | 38.39% |
| 2 | Healthcare | 16.16% |
| 3 | Consumer Discretionary | 15.09% |
| 4 | Communication Services | 14.33% |
| 5 | Financials | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Intuitive Surgical
ISRG
$167B
| $6.8M | 0.45% |
28,740
+25,470
| +779% | +$6.02M |
|
52
Assurant
AIZ
$10.7B
| $5.38M | 0.36% |
44,350
| – | – |
|
53
Vertex Pharmaceuticals
VRTX
$102B
| $5.21M | 0.35% |
19,140
+60
| +0.3% | +$16.3K |
|
54
Biogen
BIIB
$20.6B
| $4.9M | 0.33% |
17,273
-3,050
| -15% | -$865K |
|
55
Paychex
PAYX
$48.7B
| $4.75M | 0.32% |
59,535
-4,695
| -7% | -$375K |
|
56
Bank of New York Mellon
BK
$73.1B
| $4.45M | 0.3% |
129,525
-1,005
| -0.8% | -$34.5K |
|
57
SolarEdge
SEDG
$2.04B
| $4.17M | 0.28% |
17,490
-2,000
| -10% | -$477K |
|
58
Quest Diagnostics
DGX
$20.5B
| $3.52M | 0.23% |
30,700
-10,000
| -25% | -$1.14M |
|
59
Charles River Laboratories
CRL
$8.07B
| $3.16M | 0.21% |
13,965
-3,150
| -18% | -$713K |
|
|
60
Seagate
STX
$40B
| $3.1M | 0.21% |
62,813
-203,355
| -76% | -$10M |
|
61
UnitedHealth
UNH
$286B
| $2.88M | 0.19% |
9,250
| – | – |
|
62
Jack Henry & Associates
JKHY
$11.8B
| $2.59M | 0.17% |
15,915
+1,600
| +11% | +$260K |
|
63
Travelers Companies
TRV
$62B
| $2.3M | 0.15% |
21,288
-42,980
| -67% | -$4.65M |
|
64
Novo Nordisk
NVO
$245B
| $2.25M | 0.15% |
64,920
| – | – |
|
65
United Therapeutics
UTHR
$18.1B
| $2.21M | 0.15% |
21,885
+7,480
| +52% | +$755K |
|
66
Sanofi
SNY
$113B
| $2.18M | 0.15% |
43,380
| – | – |
|
67
Everest Group
EG
$14.3B
| $2.09M | 0.14% |
10,600
| – | – |
|
68
Merck
MRK
$212B
| $1.97M | 0.13% |
24,880
| – | – |
|
69
Elevance Health
ELV
$70.6B
| $1.92M | 0.13% |
7,155
| – | – |
|
70
Diodes
DIOD
$2.46B
| $1.84M | 0.12% |
32,640
+970
| +3% | +$54.8K |
|
71
Cirrus Logic
CRUS
$5.94B
| $1.84M | 0.12% |
27,240
+7,840
| +40% | +$529K |
|
72
Cohu
COHU
$950M
| $1.78M | 0.12% |
103,636
| – | – |
|
73
Kulicke & Soffa
KLIC
$1.99B
| $1.73M | 0.12% |
77,140
+18,495
| +32% | +$414K |
|
74
Stryker
SYK
$150B
| $1.71M | 0.11% |
8,210
| – | – |
|
75
Advanced Energy
AEIS
$5.8B
| $1.7M | 0.11% |
26,980
+4,000
| +17% | +$252K |
|